U.S. Centers for Disease Control and Prevention
U.S. Government: Agencies/Departments/Divisions | Federal Agencies
Recent News About U.S. Centers for Disease Control and Prevention View More
-
Opioid trial continues without Janssen; expert says oversupply caused crisis
CHARLESTON – Janssen settled with West Virginia, but the state trial continues against opioid suppliers Teva, Cephalon and Allergen continues. -
At manufacturer trial, plaintiff attorneys portray prescription opioids as dangerous
CHARLESTON – On the second day of a trial accusing opioid manufacturers of causing an drug epidemic in West Virginia, plaintiff attorneys sought to undercut a central defense contention – that prescription drugs are safe and effective in dealing with pain. -
Final two distributors provide closing arguments as federal opioid trial wraps
CHARLESTON – Attorneys for Cardinal Health and McKesson presented closing arguments in hope of convincing U.S. District Judge David Faber the distribution companies should not be held liable for any part in the opioid epidemic. -
Defense argues Cabell, Huntington treatment programs are covered; no additional funds needed
CHARLESTON – During the last day of testimony in the landmark opioid trial, the defense’s argument shifted to Cabell County and the City of Huntington’s ability to effectively cover treatment programs through federal government grants and that the governments should be able to continue to do so. -
Pain doctor shows legislative impact on opioid epidemic, then has reputation questioned
CHARLESTON – Tables turned as an expert witness for Cardinal Health had his professional reputation challenged during his testimony at the bellwether federal opioid trial. -
Expert says Huntington/Cabell need more sufficient, longstanding treatment programs
CHARLESTON – Testifying in the bellwether opioid trial, a expert witness on pharmaceutical-related abatement programs said he does not believe Cabell County has sufficient treatment programs to fight the opioid epidemic. -
Expert data shows Cabell County outweighed West Virginia, nation in prescription opioid abuse and harm
CHARLESTON – As the landmark federal opioid trial concluded its fifth week, an opioid abuse epidemiologist shared data connecting causation between prescription opioids and opioid use disorder. -
Overdose data shows growing trends of opioid-related drug poisonings
CHARLESTON – An expert epidemiologist who analyzed Cabell County and West Virginia overdose data to show opioid trends in death rates soared from 2001 to 2017. -
Emails show McKesson employees felt 'overwhelmed,' 'not possible to be truly diligent'
CHARLESTON – As the landmark federal opioid trial entered its fourth week, plaintiffs jumped into McKesson Corporation’s threshold guidelines and due diligence process. -
Distributor says it did more than necessary to abate suspicious opioid orders
CHARLESTON — As the landmark federal opioid trial entered its third week, testimony focused on two AmerisourceBergen employees who oversaw regulations involving diversion control. -
Expert says brains have similar changes with prescription and illicit opioids
CHARLESTON -- While opioid distributors have argued there is no proof of connection between prescription painkiller use and illicit drug use, an expert in the neurobiology of addiction said, during the second day of a landmark federal trial against those distributors, that people who take prescription painkillers and illicit opioids see the same changes in their brain chemistry. -
Capito sponsors another bill to regulate widely used industrial PFAS chemicals
West Virginia Republican Senator Shelley Moore Capito has sponsored three bills in recent months would regulate the use of widely used industrial chemicals known as PFAS. -
Massachusetts taking different tactic on opioid addiction by limiting prescription supply
BOSTON (Legal Newsline) —A Massachusetts law regulating opioid painkillers is the most comprehensive in the nation and contains an unusual provision that restricts first-time prescriptions to a seven-day supply. -
CDC's new opioid guidelines will be used by plaintiffs bar, WLF says
The agency’s final guidelines were released earlier this month, recommending primary care physicians use other therapies for chronic pain and exercise caution when prescribing the prescription drugs. The Washington Legal Foundation says it fears plaintiffs firms, some of which have ties to the guideline development committee, will end up using them in their pending litigation against drug makers. -
Plaintiffs firm consultant helped develop CDC's controversial opioid guidelines
The prominent plaintiffs law firm -- known for its class action lawsuits and having been hired by a number of state attorneys general in recent years -- currently is helping to represent the City of Chicago in a lawsuit filed against a group of pharmaceutical companies over the marketing of opioid painkillers.